Andrew J.M. Boulton, MD, DSc, FICP, FACP, FRCP is Professor of Medicine at the University of
Manchester and a Consultant Physician at Manchester Royal Infirmary in the United Kingdom and
a visiting Professor of Medicine at the University of Miami (Florida) School of Medicine in the
United States. He was recently appointed president of the International Diabetes Federation (IDF).
Dr. Boulton’s research focuses on diabetic nephropathy, diabetic neuropathy, and diabetic foot disease. A leader in establishing diabetic foot care as a medical subspecialty, he has received
research funding from the National Institutes of Health, the British Diabetes Association, the
European Foundation for the Study of Diabetes (EFSD), and the Wellcome Trust. He chaired the
American Diabetes Association (ADA) working groups that published the 2017 position statement
on Diabetic Neuropathy and the 2008 Comprehensive Diabetic Foot Exam.
Dr. Boulton is president of the Worldwide Initiative for Diabetes Education. He is an associate
editor of Diabetes Care and a past editor of Diabetic Medicine. He is a past president of the
European Association for the Study of Diabetes (EASD) and EFSD, was the founding Chair of the
EASD Diabetic Foot Study Group and was EASD’s Director of International Postgraduate Education.
Dr. Boulton received the first International Diabetic Foot Award in 1995, the Edward James
Olmos Award for Advocacy in Amputation Prevention in 2005, and the ADA Harold Rifkin Award
for Distinguished International Service in the Cause of Diabetes in 2008. He has authored more
than 500 articles and eight books on diabetes complications.
University of Manchester
Reaching therapeutic goals in type 2 diabetes: new options